Equity strategies

Carmignac Portfolio China New Economy

Luxembourg SICAV sub-fundEmerging marketsSRI Fund Article 8
Share Class

LU2295992320

Seize the growth potential of China's New Economy
  • Investing with conviction: Seeking companies in China's New Economy, which benefit from the country's economic transition and long-term reform.
  • Investing with selectivity: Favoring domestic quality companies which have high income visibility, while avoiding those linked to external demand.
Asset Allocation
Equities90 %
Other10 %
Data as of:  31 Dec 2024.
Risk Indicator
6/7
Recommended Minimum Investment Horizon
5 years
Cumulative Performance since launch
- 53.1 %
0.0 %
0.0 %
- 23.8 %
+ 9.1 %
From 31/03/2021
To 17/01/2025
Calendar Year Performance 2024
-
-
-
-
-
-
- 35.6 %
- 5.2 %
- 22.5 %
+ 1.0 %
Net Asset Value
46.89 €
Asset Under Management
54 M €
Market
Emerging markets
SFDR - Fund Classification

Article

8
Data as of:  17 Jan 2025.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged. The Sustainable Finance Disclosure Regulation (SFDR) 2019/2088 is a European regulation that requires asset managers to classify their funds as either 'Article 8' funds, which promote environmental and social characteristics, 'Article 9' funds, which make sustainable investments with measurable objectives, or 'Article 6' funds, which do not necessarily have a sustainability objective. For more information please refer to https://eur-lex.europa.eu/eli/reg/2019/2088/oj.

Carmignac Portfolio China New Economy fund performance

Take a look at the Fund's performance supported by our Fund managers’ market commentary and strategy insight.

Our monthly comments

Data as of:  31 Dec 2024.
Fund management team
[Management Team] [Author] Hovasse Xavier

Xavier Hovasse

Head of Emerging Equities, Fund Manager

Market environment

  • Chinese markets rose in December, ending a year of strong gains.
  • Economic indicators were mixed over the month, with the NBS manufacturing PMI down (50.5 in December compared with 51.5 in November) and the non-manufacturing PMI up (52.2 in December compared with 50 in November).
  • China's leaders have reaffirmed their intention to step up fiscal measures in the months ahead, particularly during the Two Sessions in March.
  • Over the month, the indices were up by 5.53% for the Hang Seng and 1.55% for the CSI 300.

Performance commentary

  • Against this backdrop, the fund delivered a positive performance in line with its reference indicator.
  • Our strategy benefited greatly from its allocation to the technology sector, particularly Taiwanese companies such as TSMC, Wiwynn and Elite Material.
  • Our portfolio of Chinese consumer discretionary stocks also made a positive contribution to performance, such as New Oriental Education, Yadea and H world.
  • Finally, we also benefited from our holdings in industrial stocks Sinotrans Ltd, which is involved in logistics activities, and EHang, which offers mobility solutions.

Outlook strategy

  • Although we remain constructive on the Chinese markets in the long term, we are maintaining a cautious stance in the short term, as we await further stimulus announcements from the Chinese government in the wake of Donald Trump's election as President of the United States.
  • Indeed, Donald Trump's protectionist policies, with tariffs on imports, mainly from China, and the ‘Two Sessions’ in March, are keeping the wind of uncertainty blowing.
  • We are closely monitoring each of our Chinese positions and their valuation, with the aim of remaining disciplined in calibrating our positions. We have taken profits on some of our Chinese positions, which have rebounded strongly in recent days, and for which the valuation argument has become less attractive.
  • Over the month, we added two stocks to our portfolio: Gudeng Precision Industrial, a manufacturer of photographic moulds for the semiconductor industry, and we invested in Mao Geping Cosmetics, a Chinese player in the cosmetics industry.

Performance Overview

Data as of:  17 Jan 2025.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). Morningstar Rating™ :  © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Source: Carmignac at 21/01/2025

Carmignac Portfolio China New Economy Portfolio overview

Below is an overview of the composition of the portfolio.

Geographical Breakdown

Data as of:  31 Dec 2024.
Asia97.7 %
North America2.3 %
Total % Equities100.0 %
Asia97.7 %
cnChina
64.9 %
twTaiwan
32.0 %
hkHong Kong
0.8 %

Key figures

Below are the key figures for the Fund, which will give you a clearer idea of the Fund's management and equity positioning.

Exposure Data

Data as of:  31 Dec 2024.
Equity Investment Weight90.0 %
Net Equity Exposure93.0 %
Number of Equity Issuers36
Active Share89.6 %

The strategy in a nutshell

Discover the Fund’s main features and benefits through the words of the Fund Manager.
Fund Management Team
[Management Team] [Author] Hovasse Xavier

Xavier Hovasse

Head of Emerging Equities, Fund Manager
Through an active conviction and sustainable approach, we focus on domestic companies in China's new economy that can benefit from the country's economic transition and long-term reforms.
[Management Team] [Author] Hovasse Xavier

Xavier Hovasse

Head of Emerging Equities, Fund Manager
View Fund's characteristics

Related articles

Sustainable investing15 October 2021English

Carmignac receives the ‘Label ISR’ for five additional funds

1 minute(s) read
Find out more
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
​The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performance is shown net of fees (excluding any subscription fees payable to the distributor). Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.
Carmignac Portfolio is a sub-fund of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.